Key facts
- It has raised $4.6M; the latest was Later Stage VC ($15.0M) in Nov 2024.
- Notable investors include MedTech Innovator, Entrepreneurs First, European Commission, B Heroes, Caique Holding — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for RECORNEA
- ·The full record, as it builds
Funding rounds
No funding rounds for RECORNEA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RECORNEA
Developer of a corneal medical device designed to restore the physiological curvature of the cornea with clear and predictable clinical outcomes. The company's device utilizes an implantable medical technology capable of improving the vision of patients suffering from keratoconus, enabling healthcare professionals to treat their patients with various pathological conditions that cause deformation of the cornea.
- Sector
- Healthcare
- HQ
- Trieste, Italy
- Founded
- 2019
- Employees
- 6
- Website
- recornea.com/
- Ownership
- Privately Held (backing)
RECORNEA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RECORNEA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RECORNEA in its N-PORT filings yet. We sweep new filings monthly.